Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2015 Jan 16;2903:1559-69. doi: 10.1074/jbc.M114.592246.
Show Gene links
Show Anatomy links
Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
Farmer LK
,
Schmid R
,
Evans RJ
.
???displayArticle.abstract???
P2X receptor subtype-selective antagonists are promising candidates for treatment of a range of pathophysiological conditions. However, in contrast to high resolution structural understanding of agonist action in the receptors, comparatively little is known about the molecular basis of antagonist binding. We have generated chimeras and point mutations in the extracellular ligand-binding loop of the human P2X1 receptor, which is inhibited by NF449, suramin, and pyridoxal-phosphate-6-azophenyl-2,4-disulfonate, with residues from the rat P2X4 receptor, which is insensitive to these antagonists. There was little or no effect on sensitivity to suramin and pyridoxal-phosphate-6-azophenyl-2,4-disulfonate in chimeric P2X1/4 receptors, indicating that a significant number of residues required for binding of these antagonists are present in the P2X4 receptor. Sensitivity to the P2X1 receptor-selective antagonist NF449 was reduced by ∼60- and ∼135-fold in chimeras replacing the cysteine-rich head, and the dorsal fin region below it in the adjacent subunit, respectively. Point mutants identified the importance of four positively charged residues at the base of the cysteine-rich head and two variant residues in the dorsal fin for high affinity NF449 binding. These six residues were used as the starting area for molecular docking. The four best potential NF449-binding poses were then discriminated by correspondence with the mutagenesis data and an additional mutant to validate the binding of one lobe of NF449 within the core conserved ATP-binding pocket and the other lobes coordinated by positive charge on the cysteine-rich head region and residues in the adjacent dorsal fin.
FIGURE 1. Characterization of ATP at chimeric P2X receptors.
a, location of regions AâD on an ATP-bound homology model of the P2X1 receptor. Regions AâD are shown in color; ATP is shown in yellow. Transmembrane domains are shown in dark gray. b, upper, representative traces for WT and chimeric receptors at maximal ATP concentrations. The bars represent a 3-s ATP application. Traces have been normalized to peak currents to allow for comparison. Lower, concentration-response curves for ATP. Black asterisks indicate significant shifts in EC50 from the WT P2X1 receptor, red asterisks from the P2X4 receptor, and blue asterisks from both receptors. ****, p < 0.0001.
FIGURE 2. NF449 action at chimeric P2X receptors.
a, representative traces showing the effect of NF449 (10 nm) on currents evoked by an EC90 of ATP in Xenopus oocytes expressing WT and chimeric receptors. The bars indicate a 3-s agonist/antagonist application. b, NF449 inhibition curves at an EC90 of ATP. Asterisks indicate a significant shift in IC50 from the hP2X1 receptor. *, p < 0.05; ****, p < 0.0001.
FIGURE 3. Suramin and PPADS antagonism at chimeric P2X receptors.
a, comparison of suramin action in WT receptors and chimeras. b, PPADS inhibition curves for chimeric and WT receptors. In all cases, antagonist action was determined against an EC90 of ATP. Asterisks indicate a significant shift from the WT P2X1 receptor. **, p < 0.05; ***, p < 0.0001.
FIGURE 4. Introduction of four charges reintroduced NF449 sensitivity to the X1-BX4 chimera.
a, location of Lys-136, Lys-138, Arg-139, and Lys-140 in a P2X1 receptor homology model. Docked ATP is shown in yellow. b, NF449 inhibition curves showing the effect of reintroducing the positive charges to the X1-BX4 chimera and NF449 action in the P2X4(4+) receptor. Asterisks indicate a significant difference in IC50 compared with the P2X1 receptor. ****, p < 0.0001.
FIGURE 5. Effects of NF449 at region C subchimeras.
a, location of residues swapped to generate chimeras shown in a homology model of the P2X1 receptor. Docked ATP is shown in yellow, and transmembrane domains are shown in dark gray. b, NF449 inhibition curves for subchimeras. Curves were generated at an EC90 of ATP. Asterisks represent a significant difference in IC50 compared with the P2X1 receptor. ****, p < 0.0001.
FIGURE 6. Effects of NF449 at point mutants.
a, location of point mutated residues in a P2X1 receptor homology model. Docked ATP is shown in yellow. Residues were mutated to the equivalent residue of the P2X4 receptor. b, histogram showing the -fold change in NF449 inhibition compared with the WT P2X1 receptor at an EC90 of ATP. Asterisks represent a significant difference. *, p < 0.05; **, p < 0.01.
FIGURE 7. Docking poses for the NF449-P2X1 complex.
a and b, overlay of the four docking poses AâD on the P2X1 receptor shown from different angles. The P2X1 receptor is shown in surface representation, highlighting the positively charged residues of the ATP-binding site (Lys-68, Lys-70, Arg-292, and Lys-309) in light blue, the positively charged residues of the cysteine-rich head region (Lys-136, Lys-138, Arg-139, and Lys-140) in dark blue, Thr-216 and Gln-231 in green, region X1-CγX4 (residues 210â215; see âResultsâ) in pale cyan, and His-224 in purple. NF449 poses A (red), B (orange), C (pink), and D (yellow) are shown as a mixture of sphere representation (for the core of the poses) and stick representation (for the arms of the poses). All four poses bind to the cleft between the cysteine-rich head region, ATP-binding site, and dorsal fin. c, molecular structure of the NF449 sodium salt. d, snapshot of NF449 from the pose C trajectory. NF449 and residues Lys-68, Lys-70, Lys-136, Lys-138, Arg-139, Lys-140, Thr-216, His-224, Gln-231, Arg-292, and Lys-309 are shown in stick representation. e, distances between NF449 sulfonate sulfur atoms and His-224 Nϵ (black), Thr-216 Oγ (green), and the amide nitrogen of Gln-231 monitored over the 10-ns molecular dynamics simulation of pose C. NF449/His-224 and NF449/Thr-216 interactions are present in most of the frames, and NF449/Gln-231 interactions are less stable in this simulation and are present only between 1.5 and 4.5 ns. f, section of NF449 pose C interacting with the ATP-binding site. Potential salt bridges are indicated by dashed black lines. g, section of NF449 pose A and residues Lys-136, Lys-138, and Arg-139 of the cysteine-rich head region. h, arm of NF449 pose D forming H-bonds with Thr-216 and Gln-231 side chains.
Allsopp,
The intracellular amino terminus plays a dominant role in desensitization of ATP-gated P2X receptor ion channels.
2011, Pubmed,
Xenbase
Allsopp,
The intracellular amino terminus plays a dominant role in desensitization of ATP-gated P2X receptor ion channels.
2011,
Pubmed
,
Xenbase
Bo,
A P2X purinoceptor cDNA conferring a novel pharmacological profile.
1995,
Pubmed
Brake,
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.
1994,
Pubmed
,
Xenbase
Braun,
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.
2001,
Pubmed
,
Xenbase
Browne,
New structure enlivens interest in P2X receptors.
2010,
Pubmed
Buell,
An antagonist-insensitive P2X receptor expressed in epithelia and brain.
1996,
Pubmed
Burnstock,
Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
2012,
Pubmed
Case,
The Amber biomolecular simulation programs.
2005,
Pubmed
Chataigneau,
Exploring the ATP-binding site of P2X receptors.
2013,
Pubmed
El-Ajouz,
Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop.
2012,
Pubmed
,
Xenbase
Ennion,
The role of positively charged amino acids in ATP recognition by human P2X(1) receptors.
2000,
Pubmed
,
Xenbase
Evans,
Structural interpretation of P2X receptor mutagenesis studies on drug action.
2010,
Pubmed
Evans,
Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
1995,
Pubmed
Fujiwara,
Regulation of the desensitization and ion selectivity of ATP-gated P2X2 channels by phosphoinositides.
2006,
Pubmed
,
Xenbase
Garcia-Guzman,
Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue.
1997,
Pubmed
,
Xenbase
Hattori,
Molecular mechanism of ATP binding and ion channel activation in P2X receptors.
2012,
Pubmed
Hausmann,
The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups.
2006,
Pubmed
,
Xenbase
Hechler,
A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo.
2003,
Pubmed
Hechler,
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
2005,
Pubmed
,
Xenbase
Hülsmann,
NF449, a novel picomolar potency antagonist at human P2X1 receptors.
2003,
Pubmed
,
Xenbase
Jarvis,
ATP-gated P2X cation-channels.
2009,
Pubmed
Jones,
Development and validation of a genetic algorithm for flexible docking.
1997,
Pubmed
Kaczmarek-Hájek,
Molecular and functional properties of P2X receptors--recent progress and persisting challenges.
2012,
Pubmed
Kawate,
Crystal structure of the ATP-gated P2X(4) ion channel in the closed state.
2009,
Pubmed
Oury,
Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype.
2003,
Pubmed
Rettinger,
Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
2005,
Pubmed
,
Xenbase
Roberts,
Agonist binding evokes extensive conformational changes in the extracellular domain of the ATP-gated human P2X1 receptor ion channel.
2012,
Pubmed
,
Xenbase
Royle,
Identification of a non-canonical tyrosine-based endocytic motif in an ionotropic receptor.
2002,
Pubmed
Sim,
Ectodomain lysines and suramin block of P2X1 receptors.
2008,
Pubmed
Soto,
P2X4: an ATP-activated ionotropic receptor cloned from rat brain.
1996,
Pubmed
,
Xenbase
Surprenant,
Signaling at purinergic P2X receptors.
2009,
Pubmed
Valera,
A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP.
1994,
Pubmed
,
Xenbase
Xiong,
Role of extracellular histidines in antagonist sensitivity of the rat P2X4 receptor.
2004,
Pubmed
,
Xenbase
Young,
P2X receptors: dawn of the post-structure era.
2010,
Pubmed